Exhaled carbon monoxide in sarcoidosis

G. Ciarleglio, V. A. M. Martino, M. Pieroni, M. Refini, P. Rottoli, P. Sestini (Siena, Italy)

Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Session: Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Session type: Poster Discussion
Number: 4081
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Ciarleglio, V. A. M. Martino, M. Pieroni, M. Refini, P. Rottoli, P. Sestini (Siena, Italy). Exhaled carbon monoxide in sarcoidosis. Eur Respir J 2004; 24: Suppl. 48, 4081

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled carbon monoxide in lung disease
Source: Eur Respir J 2003; 21: 197
Year: 2003


Exhaled carbon monoxide in childhood asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Exhaled carbon monoxide in pulmonary sarcoidosis: clinical correlations
Source: Eur Respir J 2005; 26: Suppl. 49, 79s
Year: 2005

Exhaled carbon monoxide in healthy children
Source: Eur Respir J 2005; 26: Suppl. 49, 677s
Year: 2005

Exhaled carbon monoxide levels during treatment of acute asthma
Source: Eur Respir J 2001; 17: 1336
Year: 2001


Exhaled carbon monoxide: mechanisms and clinical applications
Source: Eur Respir Monogr 2010; 49: 82-95
Year: 2010


Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 423s
Year: 2002

Exhaled carbon monoxide level in asthmatic and healthy children
Source: Eur Respir J 2006; 28: Suppl. 50, 259s
Year: 2006

Exhaled carbon monoxide in asthma: a prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 413s
Year: 2003

The importance of measuriing exhaled carbon monoxide in asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003

Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD)
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001

Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008

Increase of exhaled carbon monoxide in subjects with non-controlled asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Exhaled gases
Source: Annual Congress 2009 - PG8 Asthma: monitoring airway disease
Year: 2009



Bronchial blood flow is normal in COPD patients and is positevily correlated with exhaled nitric oxide and the diffusion of carbon monoxide
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006

Exhaled carbon monoxide in patients with bronchiolitis obliterans after lung transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 327s
Year: 2003

Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis
Source: Eur Respir J 2002; 20: 92-99
Year: 2002



Theoretical basis for carbon monoxide measurements in exhaled air
Source: Eur Respir J 2001; 18: Suppl. 33, 136s
Year: 2001

Measurement of exhaled carbon monoxide in children with sickle cell disease
Source: Eur Respir J 2002; 20: Suppl. 38, 139s
Year: 2002

Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008